UPDATED RESULTS OF A PHASE II STUDY OF LENALIDOMIDE AND RITUXIMAB IN RELAPSED/REFRACTORY (R/R) CHRONIC LYMPHOCYTIC LEUKEMIA.

被引：0
|
作者：
Piris-Villaespesa, M. [1 ]
Chavez, J. [2 ]
Dalia, S. [2 ]
Veliz, M. [3 ]
Lancet, Jeffrey [2 ]
Bello, C. [2 ]
Turba, E. [2 ]
Shah, B. [2 ]
Komrokji, R. [2 ]
Sokol, L. [2 ]
Locke, F. [4 ]
Kharfan-Dabaja, M. [4 ]
Sotomayor, E. [2 ]
Pinilla-Ibarz, J. [2 ]
机构：
[1] Hosp Univ Puerta de Hierro Majadahonda, Hematol, Madrid, Spain
[2] H Lee Moffitt Canc Ctr & Res Inst, Malignant Hematol, Tampa, FL USA
[3] Cent Florida Hematol Onc, Hematol, Tampa, FL USA
[4] H Lee Moffitt Canc Ctr & Res Inst, Bone Marrow Transplant, Tampa, FL USA
来源：
HAEMATOLOGICA | 2013年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P108
引用
收藏
页码：46 / 46
页数：1
相关论文
共 50 条
  • [41] Combination of Ofatumumab and Lenalidomide in Patients with Relapsed Chronic Lymphocytic Leukemia (CLL): Results of a Phase II Trial
    Ferrajoli, Alessandra
    Falchi, Lorenzo
    O'Brien, Susan
    Wierda, William
    Faderl, Stefan
    Smith, Susan C.
    Ayala, Ana B.
    Kantarjian, Hagop M.
    Keating, Michael J.
    BLOOD, 2012, 120 (21)
  • [42] Combination of Ofatumumab and Lenalidomide In Patients with Relapsed Chronic Lymphocytic Leukemia: Initial Results of a Phase II Trial
    Badoux, Xavier
    O'Brien, Susan
    Wierda, William G.
    Faderl, Stefan
    Estrov, Zeev
    Yerrow, Kimberly
    Kantarjian, Hagop M.
    Keating, Michael J.
    Ferrajoli, Alessandra
    BLOOD, 2010, 116 (21) : 1023 - 1024
  • [43] ABT-199 (GDC-0199) combined with rituximab (R) in patients (pts) with relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL): Interim results of a phase 1b study.
    Ma, Shuo
    Seymour, John Francis
    Lanasa, Mark C.
    Kipps, Thomas J.
    Barrientos, Jacqueline Claudia
    Davids, Matthew Steven
    Mason-Bright, Tanita
    Rudersdorf, Nikita
    Yang, Jianning
    Munasinghe, Wijith
    Zhu, Ming
    Cerri, Elisa
    Enschede, Sari H.
    Humerickhouse, Rod
    Roberts, Andrew Warwick
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [44] PHASE I STUDY OF R05072759 (GA101) IN RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA
    Cartron, G.
    Lamy, T.
    Morschhauser, F.
    Milpied, N.
    Thieblemont, C.
    Tilly, H.
    Birkett, J.
    Pisa, P.
    Salles, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 201 - 201
  • [45] Final Results of a Phase 1/2 Study of SYK Inhibitor Entospletinib in Combination with Obinutuzumab in Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)
    Danilov, Alexey V.
    Lam, Vi
    Bria, Thurlow
    Spurgeon, Stephen E.
    Park, Byung
    Orand, Kirsten
    Kittai, Adam S.
    BLOOD, 2021, 138
  • [46] Venetoclax-Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia
    Seymour, J. F.
    Kipps, T. J.
    Eichhorst, B.
    Hillmen, P.
    D'Rozario, J.
    Assouline, S.
    Owen, C.
    Gerecitano, J.
    Robak, T.
    De la Serna, J.
    Jaeger, U.
    Cartron, G.
    Montillo, M.
    Humerickhouse, R.
    Punnoose, E. A.
    Li, Y.
    Boyer, M.
    Humphrey, K.
    Mobasher, M.
    Kater, A. P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (12): : 1107 - 1120
  • [47] Pentostatin with an alkylating agents in refractory or relapsed chronic lymphocytic leukemia.
    Jajeh, A
    Ali, S
    Abboud, W
    Hadad, L
    Zalzaleh, G
    BLOOD, 2002, 100 (11) : 366B - 366B
  • [48] R2: Preliminary Results of a Phase II Study of Lenalidomide and Rituximab in Relapsed Refractory Indolent Non-Hodgkin's Lymphoma (NHL).
    Dutia, Mrinal
    DeRoock, Ian
    Chee, Karen
    O'donnell, Robert
    Quirch, Christine
    Reed-Pease, Christine
    Tuscano, Joseph
    BLOOD, 2009, 114 (22) : 670 - 670
  • [49] R2: Preliminary Results of a Phase II Study of Lenalidomide and Rituximab in Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma (NHL)
    DeRook, Ian
    Odonnell, Robert T.
    Noble, B.
    Quirch, C.
    Tuscano, Joseph
    BLOOD, 2008, 112 (11) : 1052 - 1052
  • [50] Comparison of Phase 3 Ibrutinib Results Versus Standard of Care in Sweden in Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)
    Osterborg, Anders
    Asklid, Anna
    Diels, Joris
    Repits, Johanna
    Soltoft, Frans
    Hansson, Lotta
    Jaeger, Ulrich
    BLOOD, 2015, 126 (23)
12345